Skip to content
Review Open access

Dynamic glucose-enhanced MRI in brain tumors.

Aug 2026 · MAGMA · 0 citations · 139 references
Medicine

TL;DR

An overview of DGE MRI and its potential applications in brain tumor imaging is provided, including the physical principles underlying the contrast mechanisms and current acquisition strategies and post-processing approaches, including quantification and kinetic modeling.

Abstract

Dynamic glucose-enhanced (DGE) MRI is an emerging imaging technique that provides information on sugar uptake with contributions from delivery (perfusion), transport (membrane permeability), and metabolism in vivo. DGE MRI contrast reflects changes in water magnetization caused by changes in sugar concentration, which can be detected through chemical exchange between water protons and sugar hydroxyl protons. Such contrast can be visualized using chemical exchange-sensitive saturation transfer (CEST), on- and off-resonance spin-lock (CESL), and T 2 relaxation-based approaches. These methods enable the use of biodegradable sugars as contrast agents, which are expected to have fewer side effects than conventional gadolinium-based MRI contrast agents and are more affordable and environmentally friendly. In this review, part of the special issue "New MR imaging techniques in Oncology," we provide an overview of DGE MRI and its potential applications in brain tumor imaging. We introduce the physical principles underlying the contrast mechanisms and summarize current acquisition strategies and post-processing approaches, including quantification and kinetic modeling. Technical challenges such as small signal changes, motion sensitivity, and inhomogeneities in static ( B 0 ) and radiofrequency ( B 1 ) magnetic fields are discussed. Special attention is given to glucose physiology and pharmacokinetics, including administration methods. Throughout, we summarize preclinical and early patient studies in brain tumors and compare DGE MRI with other functional and molecular imaging techniques using MRI and PET. Finally, we discuss future directions for clinical translation, emphasizing the need for standardized protocols and improved acquisition and post-processing strategies.

Read PDF

Similar papers

Open access Aug 2026

CEST MRI of glucosamine uptake in brain tumor-bearing mice

Increased reliance on anaerobic glycolysis is a hallmark of cancer metabolism that is traditionally used by FDG-PET for lesions and metastases detection. Glucose-based chemical exchange saturation transfer (glucoCEST) MRI offers an alternative, non-radioactive approach for characterizing metabolic changes. In this...

M. Rivlin, Yaniv Yosha, Gil Navon et al. · 0 citations
Open access Sep 2026

Toward Cell-Specific Molecular MRI: Modulating Chemical Exchange Saturation Transfer Contrast With Manganese.

Chemical exchange saturation transfer (CEST) MRI enables sensitive detection of low-concentration metabolites in vivo, but its biological interpretation is limited by the composite nature of the signal, which reflects contributions from multiple cell types. In the brain, these include intracellular metabolites in neuro...

E. Cavallari, V. Bitonto, Morgana Giachello et al. · 0 citations
Review Open access Aug 2026

Recent advances in arterial spin labeling MRI for imaging brain tumors.

The future potential of ASL MRI is seen not only in replacing contrast agents for perfusion assessment but also in providing additional information to the MRI exam, such as BBB integrity or the architecture of the vascular feeders.

Gabriel Hoffmann, M. V. van Osch · 0 citations
Review Open access Sep 2026

The role of diffusion-weighted imaging in breast cancer: from diagnosis to treatment monitoring and follow-up.

Diffusion-weighted imaging (DWI) is a fundamental non-contrast sequence in multiparametric breast magnetic resonance imaging (MRI), measuring water diffusion to assess tissue microstructure. The derived apparent diffusion coefficient (ADC) effectively discriminates between malignant lesions, which typically exhibit low...

Yong Ye, Wen-Wen Shao, Ying Yang · 0 citations
Review Aug 2026

From metabolite mapping to precision imaging: advances in in vivo MR spectroscopy of brain tumours.

Magnetic resonance spectroscopy (MRS) provides non-invasive in vivo assessment of brain tumour metabolism and complements conventional magnetic resonance imaging (MRI) by adding biochemical information beyond structural imaging. This narrative state-of-the-art review summarises current clinical and emerging application...

Maninder Singh, D. Dwivedi, N. Jagannathan · 0 citations
Review Open access Aug 2026

Functional imaging beyond anatomy: The emerging role of magnetic resonance spectroscopy and metabolic biomarkers in monitoring targeted cancer therapy

It is argued that the field is transitioning from proof-of-principle pharmacodynamic studies toward standardised, biomarker-guided adaptive therapy, and that the principal barriers — technical harmonisation, quantification standards and prospective validation — are now well defined and addressable.

Hao Sun, Xiao-Jun Dong, Jinze Yu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.